Iqure Pharma

Developer of therapeutics for neuropathic pain

placePrinceton, New Jersey, United States calendar_todayFounded 2019 groups6 employees language iqurepharma.com

Innovation

1 patent family; filing pace active.

YearFilings
20251

Social engagement

Social engagement: 709 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Keiretsu Forum Mid-Atlantic.

Investor typeCountShare
Angel & family office267%
Other / undisclosed133%

Recent activity

3 Jun 2026
Milestone
regulatory
27 May 2026
Product launch
iQure
29 Apr 2026
Event
BioEquity Europe 2026
Coming soon